Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Onconova Therapeutics Inc. logo

Onconova Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

1.00
 
USD
  
0.00
  
(-0.47%)
Optionable: Yes  Market Cap: 19 M  90-day average vol: 148,489

Previous close: 1.0  Open: 1.02  Bid:   Ask:
52 week range    
0.55   
   1.33
Peers   
CYCC / 
ARRY / 
SPPI / 
BAX / 
Last updated: Monday 20th May 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ARRY

2 B-38.79.53

BAX

0.012943 B35.986.87

CTIC

0 B-2.32

CYCC

0 B-13.36

SPPI

0 B-0.70.6707
Financials

ONTX Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccretionOnPreferredStock2 M
AccruedPreferredStockDividends-204 M
Basic EPS total-0.96-0.91
Basic weighted shares outstanding706281.01 M2 M295109.0600021.0274938.0958965.012 M17 M21 M
Depreciation-446000.0-55000.0-14000.0-13000.0-14000.0-14000.0
DepreciationAndAmortization-446000.0-55000.0-14000.0-13000.0-14000.0-14000.0
Diluted EPS total-91.8-44.1-15.75-66.6-40.2-74.85-22.35-2.1-0.96-0.91
Diluted normalized net income/share-22.35-2.1
Diluted weighted shares outstanding387657.01 M2 M295300.0599303.0270501.0958965.012 M17 M21 M
GainOnSaleOfBusiness824000.0
GainOnSaleOfSecurity80 M-21 M
GeneralAndAdministrativeExpense17 M15 M10 M9 M7 M8 M8 M8 M9 M8 M
Gross operating profit5 M800000.011 M6 M787000.01 M2 M231000.0226000.0226000.0
Income before tax-62 M-64 M-24 M-20 M-24 M-21 M-21 M-25 M-16 M-19 M
Income restructuring and M&A-1 M-1 M
Income taxes435000.019000.016000.014000.013000.0-124000.010000.04000.0
Interest income651000.0
InterestExpenseNonOperating4000.02000.0
InterestIncomeOperating500000.0
MinorityInterests13000.0113000.044000.0-163000.0
MiscOtherSpecialCharges105000.0-32000.0-35000.04 M2 M3 M206000.0-160000.0333000.0663000.0
Net income from total operations-63 M-64 M-24 M-20 M-24 M-41 M-22 M-25 M-16 M-19 M
NetIncomeCommonStockholders-65 M-64 M-24 M-20 M-24 M-41 M-22 M-25 M-16 M-19 M
NetIncomeContinuousOperations-63 M-64 M-24 M-20 M-24 M-41 M-22 M-25 M-16 M-19 M
NetNonOperatingInterestIncomeExpense-4000.0-2000.0651000.0
Operating income-62 M-64 M-24 M-24 M-26 M-23 M-22 M-25 M-16 M-20 M
Operating income before depreciation (EBITDA)-62 M-63 M-24 M-20 M-24 M-20 M-21 M-25 M-16 M-19 M
OperatingExpense-67 M-65 M-35 M-29 M-27 M-25 M24 M25 M-17 M-20 M
Other income net-105000.032000.035000.0-4 M-2 M18 M-206000.0160000.0-333000.0-663000.0
OtherGandA17 M15 M10 M9 M7 M8 M8 M8 M9 M8 M
OtherOperatingExpenses-67 M-65 M
OtherunderPreferredStockDividend2 M
PreferredStockDividends2 M
RealizedCapitalGain6 M
RentAndLandingFees17 M15 M10 M9 M7 M8 M-158000.09 M8 M
Research & development expense50 M49 M26 M20 M19 M17 M16 M17 M7 M11 M
ResearchExpense50 M49 M26 M20 M19 M17 M16 M17 M7 M11 M
RestructringAndMnAIncome-1 M-1 M
SalariesAndWages-8 M-5 M-4 M-4 M-2 M-1 M-1 M-369000.0-576000.0-1 M
Selling Gen & administrative expense17 M15 M10 M9 M7 M8 M8 M8 M9 M8 M
Special income/charges1 M1 M
Total Income available for interest expense (EBIT)-62 M-64 M-24 M-20 M-24 M-21 M-21 M-25 M-16 M-19 M
Total common shares outstanding9616.09645.012178.030100.084205.0393000.022 M16 M21 M21 M
Total net income-63 M-64 M-24 M-20 M-24 M-41 M-22 M-25 M-16 M-19 M
Total ordinary shares21 M21 M21 M21 M21 M21 M21 M21 M21 M21 M
Total revenues5 M800000.011 M6 M787000.01 M2 M231000.0226000.0226000.0
TotalExpenses-67 M-65 M-35 M-29 M-27 M-25 M24 M25 M-17 M-20 M
TotalRevenue5 M800000.011 M6 M787000.01 M2 M231000.0226000.0226000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University